Hieronymus, Fredrik http://orcid.org/0000-0003-0930-6068
Kølbæk, Pernille
Correll, Christoph U.
Østergaard, Søren D.
Funding for this research was provided by:
Lundbeckfonden (R358-2020-2341, R344-2020-1073)
Novo Nordisk Fonden (NNF20SA0062874)
Kræftens Bekæmpelse (R283-A16461)
Det Frie Forskningsråd (7016-00048B)
Article History
Received: 2 March 2021
Accepted: 20 July 2021
First Online: 27 August 2021
Competing interests
: C.U.C. has been a consultant and/or advisor to or has received honoraria from Acadia, Alkermes, Allergan, Angelini, Axsome, Gedeon Richter, Gerson Lehrman Group, IntraCellular Therapies, Janssen/J&J, LB Pharma, Lundbeck, MedAvante-ProPhase, Medscape, Mylan, Neurocrine, Noven, Otsuka, Pfizer, Recordati, Rovi, Sumitomo Dainippon, Sunovion, Supernus, Takeda, and Teva. He has provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Lundbeck, Rovi, Supernus, and Teva. He received royalties from UpToDate and grant support from Janssen and Takeda. He is also a stock option holder of LB Pharma. S.D.Ø. received the 2020 Lundbeck Foundation Young Investigator Prize. The remaining authors declare no competing interests. Aarhus University, The Feinstein Institute for Medical Research, and MedAvante-ProPhase Inc. each hold one-third of the copyright for the Simplified Negative and Positive Symptoms Interview (SNAPSI).